Keywords: king, pharma, posts, leap, earnings, usa, pharmaceuticals
King Pharma posts 36% leap in earnings
Article | 05 August 2002
The USA's King Pharmaceuticals has posted net earnings totaling $77.1million for second-quarter 2002, a jump of 36% (excluding charges) on the like, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
